These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23759083)

  • 1. Proper analysis in clinical trials: how to report and adjust for missing outcome data.
    Joshi M; Royuela A; Zamora J
    BJOG; 2013 Jul; 120(8):915-9. PubMed ID: 23759083
    [No Abstract]   [Full Text] [Related]  

  • 2. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 3. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.
    Sterne JA; Jüni P; Schulz KF; Altman DG; Bartlett C; Egger M
    Stat Med; 2002 Jun; 21(11):1513-24. PubMed ID: 12111917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling missing data issues in clinical trials for rheumatic diseases.
    Wong WK; Boscardin WJ; Postlethwaite AE; Furst DE
    Contemp Clin Trials; 2011 Jan; 32(1):1-9. PubMed ID: 20840873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quo vadis meta-analysis? A potentially dangerous tool if used without adequate rules.
    Michels KB
    Important Adv Oncol; 1992; ():243-8. PubMed ID: 1582676
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of multiple endpoints in clinical trials: it's time for the designations of primary, secondary and tertiary to go.
    Snapinn S; Jiang Q
    Pharm Stat; 2011; 10(1):1-2. PubMed ID: 20029938
    [No Abstract]   [Full Text] [Related]  

  • 8. Five easy pieces on evidence-based medicine (4).
    Kalso E; Edwards J; McQuay HJ; Moore RA
    Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232
    [No Abstract]   [Full Text] [Related]  

  • 9. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 10. Error message.
    Vaux DL
    Nature; 2004 Apr; 428(6985):799. PubMed ID: 15103350
    [No Abstract]   [Full Text] [Related]  

  • 11. Missing data mechanisms in a dose-finding adaptive trial.
    Liu K; Entsuah R
    J Biopharm Stat; 2012; 22(2):329-37. PubMed ID: 22251177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary.
    Breslow NE
    Biostatistics; 2010 Jul; 11(3):379-80. PubMed ID: 20538870
    [No Abstract]   [Full Text] [Related]  

  • 13. Reproducible research and the substantive context.
    Keiding N
    Biostatistics; 2010 Jul; 11(3):376-8. PubMed ID: 20498225
    [No Abstract]   [Full Text] [Related]  

  • 14. Discussion of Keiding.
    Peng RD
    Biostatistics; 2010 Jul; 11(3):393-4. PubMed ID: 20538876
    [No Abstract]   [Full Text] [Related]  

  • 15. Missing data in trials: do we have to keep carrying the last observation forward?
    Boers M
    Arthritis Rheum; 2008 Jan; 59(1):2-3. PubMed ID: 18163416
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis: methods, strengths, and weaknesses.
    Buyse M; Piedbois P; Piedbois Y; Carlson RW
    Oncology (Williston Park); 2000 Mar; 14(3):437-43; discussion 444, 447. PubMed ID: 10742969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II--design and analysis.
    Coleman WP; Woodbury-Harris KM; Coull BM
    Front Neurol Neurosci; 2009; 25():52-54. PubMed ID: 19478496
    [No Abstract]   [Full Text] [Related]  

  • 19. Stopping a clinical trial properly.
    Whitehead J
    Lancet; 1999 Jun; 353(9170):2164. PubMed ID: 10382734
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylprednisolone in acute spinal cord injury: a tarnished standard.
    Miller SM
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):140-2. PubMed ID: 18362778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.